ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Roswell Park Wins High Priority Score, Full Budget Recommendation For Core Grant.

January 11, 2008

Litton Awarded $342,618 For Frederick Fee

February 21, 1975

NCI RFA Available: Minority-Based CCOPS

August 15, 1997

Emory Cancer Experiment Launched Into Space

January 17, 2003

In Brief: Deadline June 1 For Cancer Research Institute Grants; Chabner To Present Karnofsky Lecture

May 3, 1985

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013